Friday, 18 Oct 2019

You are here

Risk of Steroid-Induced Diabetes Quantified

Glucocorticoid (or steroid) therapy is a well-known risk factor for diabetes. But what dose, given how and for how long?  Dixon and colleagues from the The University of Manchester have quantified the risk of diabetes associated with steroid use.  (Citation source http://buff.ly/1TqZR0Q)

Overall they found a 30-60% increased risk of diabetes with steroid use. The risk was greatest with current/recent steroid use compared to long term steroid use. Whereas doses less than 5 mg per day had very little risk of diabetes, 5 mg of prednisolone equivalent dose for the last 1, 3, and 6 months was significantly associated with HRs of 1.20, 1.43, and 1.48, respectively, compared to nonusers.

Patients taking much higher doses (30 mg qd) were associated with an even greater risk, ranging from a 3-fold to 10-fold risk of DM if taken for 1, 3 or 6 months. They also found that glucocorticoids were associated with one new case of diabetes for every 150-200 people treated per year.

They correlated steroid doses with the risk of DM using rheumatoid arthritis patients from two different databases a UK primary care databases - the Clinical Practice Research Datalink [CPRD]) 21,962 RA patients) and the US National Data Bank for Rheumatic Diseases (NDB) 12,657 RA patients.

 

 

Add new comment

More Like This

Joint Injections: Are They Worth the Risk?

Intra-articular injections of corticosteroids for relief of the pain of hip or knee osteoarthritis (OA) may have adverse long-term consequences, researchers suggested.

Hydroxychloroquine Blood Levels May Predict Future Retinopathy

A study of 527 patients receiving daily hydroxychloroquine (HCQ) concluded that hydroxychloroquine blood levels may predict future HCQ retinopathy.

This study assessed whether lower HCQ dosing, as recommended by the 2016 American Academy of Ophthalmology (AAO) guidelines (less than 5 mg/kg), would favorably affect retinopathy outcomes.

Arthritis Foundation Releases First CBD Guidance for Adults With Arthritis

As the leading organization for people with arthritis, the Arthritis Foundation has just released the first CBD guidance for adults with arthritis. CBD, or cannabidiol, a plant-based compound, has become popular among people with arthritis seeking to ease chronic joint pain.

Persistent Inflammatory Arthritis After Immune Checkpoint Inhibitors

Braaten and colleagues from Johns Hopkins School of Medicine have reported their experience with chronic inflammatory arthritis induced by immune checkpoint inhibitor therapies, showing that in some, inflammatory arthritis persists after the immunotherapy has been discontinued.

Checkpoint Inhibitors: Who Gets Myocarditis?

The usual risk factors for myocarditis may not apply to who gets it while on immune checkpoint inhibiting cancer drugs, an FDA adverse event database suggested.